I’m a holder of rgs but I tend to agree. No quantitative data in announcement and no news as to where next. More information is needed before a rerate. Though given our cash position and number of products in the pipeline I’m happy to keep this one in the bottom draw.
Ann: Regeneus Announces Successful Results in Acne Study, page-8
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $4.653M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 39.0¢ | $4.139K | 10.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2780 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 12470 | 1 |
View Market Depth
| Last trade - 10.54am 02/10/2024 (20 minute delay) ? |
| CMB (ASX) Chart |